Pfizer Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Pfizer Inc
PFE Stock  USD 25.13  0.19  0.76%   
Pfizer financial statements provide useful quarterly and yearly information to potential Pfizer Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Pfizer financial statements helps investors assess Pfizer's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Pfizer's valuation are summarized below:
Gross Profit
66.2 B
Profit Margin
0.0716
Market Capitalization
141.3 B
Enterprise Value Revenue
3.3347
Revenue
59.4 B
There are over one hundred nineteen available trending fundamental ratios for Pfizer Inc, which can be analyzed over time and compared to other ratios. Investors should ensure to check out all of Pfizer's recent performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 126.1 B. The current year's Enterprise Value is expected to grow to about 87.3 B

Pfizer Total Revenue

39.48 Billion

Check Pfizer financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pfizer's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.6 B, Interest Expense of 2.3 B or Total Revenue of 39.5 B, as well as many indicators such as Price To Sales Ratio of 4.61, Dividend Yield of 0.0598 or PTB Ratio of 1.73. Pfizer financial statements analysis is a perfect complement when working with Pfizer Valuation or Volatility modules.
  
Check out the analysis of Pfizer Correlation against competitors.

Pfizer Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets237.8 B226.5 B170.3 B
Slightly volatile
Short and Long Term Debt Total78.8 B75 B42.4 B
Slightly volatile
Other Current Liabilities28.9 B27.5 B15.7 B
Slightly volatile
Total Current Liabilities50.2 B47.8 B31.4 B
Slightly volatile
Total Stockholder Equity46.9 B89 B67.2 B
Slightly volatile
Property Plant And Equipment Net11.3 B18.9 B13.4 B
Slightly volatile
Net Debt75.8 B72.2 B39.4 B
Slightly volatile
Retained Earnings124.3 B118.4 B82 B
Slightly volatile
Cash2 B2.9 B2.6 B
Slightly volatile
Non Current Assets Total192.3 B183.2 B125.2 B
Slightly volatile
Non Currrent Assets Other5.3 B9.1 B5 B
Slightly volatile
Cash And Short Term Investments14.9 B12.7 B20.8 B
Pretty Stable
Net Receivables8.7 B11.2 B12.1 B
Very volatile
Common Stock Shares Outstanding5.7 B5.7 B4.8 B
Very volatile
Liabilities And Stockholders Equity237.8 B226.5 B170.3 B
Slightly volatile
Non Current Liabilities Total93.9 B89.4 B68.3 B
Slightly volatile
Inventory5.2 B10.2 B7.1 B
Slightly volatile
Other Current Assets9.7 B9.3 B3.3 B
Slightly volatile
Total Liabilities144.1 B137.2 B99.7 B
Slightly volatile
Property Plant And Equipment Gross36.7 B35 B19.1 B
Slightly volatile
Total Current Assets32.2 B43.3 B44.2 B
Very volatile
Short Term Debt5.7 B10.9 B6.8 B
Pretty Stable
Intangible Assets68.1 B64.9 B41.1 B
Slightly volatile
Property Plant Equipment11.3 B18.9 B13.4 B
Slightly volatile
Accounts Payable7 B6.7 B4.5 B
Slightly volatile
Common Stock Total Equity474 M478 M446.9 M
Slightly volatile
Short Term Investments9.3 B9.8 B18.2 B
Pretty Stable
Capital Stock474 M478 M446.9 M
Slightly volatile
Common Stock474 M478 M446.9 M
Slightly volatile
Other Liabilities22.1 B26.9 B26.4 B
Pretty Stable
Other Assets5 B6.7 B4.9 B
Slightly volatile
Long Term Debt63.5 B60.5 B34.8 B
Slightly volatile
Good Will40.7 B67.8 B47 B
Slightly volatile
Current Deferred Revenue3.9 B2.7 B4.2 B
Very volatile
Preferred Stock Total Equity14.5 M15.3 M36.9 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity265.1 M274 M318.9 M
Slightly volatile
Retained Earnings Total Equity87 B118.4 B82 B
Slightly volatile
Long Term Debt Total39.6 B61.5 B36.1 B
Slightly volatile
Capital Surpluse90 B92.6 B83.1 B
Slightly volatile
Deferred Long Term Liabilities608 M640 M12.5 B
Slightly volatile
Long Term Investments15.1 B15.4 B14.1 B
Pretty Stable
Non Current Liabilities Other17.2 B16.5 B21.2 B
Pretty Stable
Short and Long Term Debt7.8 B10.3 B6 B
Slightly volatile
Cash And Equivalents1.8 B2.9 B2 B
Slightly volatile
Net Invested Capital132 B159.9 B117.9 B
Slightly volatile

Pfizer Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization6.6 B6.3 B3.4 B
Pretty Stable
Total Revenue39.5 B58.5 B54.2 B
Slightly volatile
Gross Profit30.4 B28.8 B39.9 B
Pretty Stable
Other Operating Expenses28.8 B55.1 B39.7 B
Slightly volatile
Operating Income3.2 B3.4 B14.7 B
Pretty Stable
EBIT3.1 B3.3 B16.5 B
Very volatile
EBITDA15.4 B9.6 B20.3 B
Pretty Stable
Cost Of Revenue31.2 B29.7 B15.8 B
Slightly volatile
Total Operating Expenses19.8 B25.4 B25.4 B
Pretty Stable
Income Before Tax1 B1.1 B12.1 B
Pretty Stable
Net Income2 B2.1 B12.2 B
Pretty Stable
Selling General Administrative12.9 B11.1 B11.6 B
Very volatile
Research Development8.2 B10.7 B8.5 B
Slightly volatile
Net Income Applicable To Common Shares37.9 B36.1 B17.3 B
Slightly volatile
Net Income From Continuing Ops2.1 B2.2 B11.7 B
Pretty Stable
Non Recurring1.3 B2.1 B1.5 B
Slightly volatile
Selling And Marketing Expenses2.2 B3.7 B2.8 B
Pretty Stable
Interest Income924.4 M1.6 B1.1 B
Slightly volatile
Reconciled Depreciation4.2 B6.3 B5.7 B
Slightly volatile

Pfizer Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow4.6 B4.8 B13.9 B
Very volatile
Begin Period Cash Flow444.6 M468 M2.4 B
Slightly volatile
Depreciation4.1 B6.3 B5.6 B
Very volatile
Dividends Paid5.2 B9.2 B7 B
Slightly volatile
Capital Expenditures4.1 B3.9 B2.2 B
Slightly volatile
Total Cash From Operating Activities12.4 B8.7 B16.4 B
Pretty Stable
Net Income2 B2.1 B12.3 B
Pretty Stable
End Period Cash Flow2.2 B2.9 B2.7 B
Slightly volatile
Stock Based Compensation551.2 M525 M656 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.612.77733.6061
Slightly volatile
Dividend Yield0.05980.05690.0384
Slightly volatile
PTB Ratio1.731.82512.8203
Pretty Stable
Days Sales Outstanding79.8169.741661.9342
Pretty Stable
Book Value Per Share16.6115.822811.6121
Slightly volatile
Free Cash Flow Yield0.04460.02950.0676
Pretty Stable
Operating Cash Flow Per Share1.431.54172.6386
Slightly volatile
Stock Based Compensation To Revenue0.00930.0090.0118
Slightly volatile
Capex To Depreciation1.230.62110.5627
Very volatile
PB Ratio1.731.82512.8203
Pretty Stable
EV To Sales3.664.01144.1569
Slightly volatile
Free Cash Flow Per Share1.210.84942.2906
Pretty Stable
ROIC0.04070.04290.1288
Very volatile
Inventory Turnover3.062.91362.0104
Slightly volatile
Net Income Per Share0.360.37552.0178
Pretty Stable
Days Of Inventory On Hand119125209
Slightly volatile
Payables Turnover2.644.42433.3919
Very volatile
Sales General And Administrative To Revenue0.330.18930.2379
Slightly volatile
Research And Ddevelopement To Revenue0.130.18260.1541
Pretty Stable
Capex To Revenue0.06050.06680.0433
Slightly volatile
Cash Per Share1.672.24883.274
Very volatile
POCF Ratio22.1218.673813.5138
Slightly volatile
Interest Coverage1.441.520612.645
Pretty Stable
Payout Ratio4.584.36391.1359
Slightly volatile
Capex To Operating Cash Flow0.310.44910.1925
Very volatile
PFCF Ratio41.533.895720.0061
Very volatile
Days Payables Outstanding13882.4991118
Very volatile
Income Quality4.284.07881.7876
Slightly volatile
ROE0.02260.02380.1765
Pretty Stable
EV To Operating Cash Flow24.026.971316.0181
Slightly volatile
PE Ratio80.576.669225.3139
Slightly volatile
Return On Tangible Assets0.02150.02260.1524
Very volatile
EV To Free Cash Flow44.3648.956823.5012
Pretty Stable
Earnings Yield0.01240.0130.0609
Slightly volatile
Intangibles To Total Assets0.620.58580.497
Slightly volatile
Net Debt To EBITDA7.937.55342.5442
Slightly volatile
Current Ratio1.740.90671.6454
Slightly volatile
Receivables Turnover4.225.23366.0625
Slightly volatile
Graham Number10.511.544521.4596
Slightly volatile
Shareholders Equity Per Share16.5615.774211.565
Slightly volatile
Debt To Equity0.850.80760.5755
Slightly volatile
Capex Per Share0.730.69240.382
Slightly volatile
Revenue Per Share10.8810.36619.1947
Slightly volatile
Interest Debt Per Share13.7913.13087.1867
Slightly volatile
Debt To Assets0.160.31740.2247
Slightly volatile
Enterprise Value Over EBITDA15.6324.552713.1149
Slightly volatile
Short Term Coverage Ratios0.80.84063.5283
Pretty Stable
Price Earnings Ratio80.576.669225.3139
Slightly volatile
Operating Cycle350195281
Pretty Stable
Price Book Value Ratio1.731.82512.8203
Pretty Stable
Days Of Payables Outstanding13882.4991118
Very volatile
Dividend Payout Ratio4.584.36391.1359
Slightly volatile
Price To Operating Cash Flows Ratio22.1218.673813.5138
Slightly volatile
Price To Free Cash Flows Ratio41.533.895720.0061
Very volatile
Pretax Profit Margin0.01720.01810.2108
Pretty Stable
Ebt Per Ebit0.30.3150.7688
Slightly volatile
Operating Profit Margin0.05460.05740.2546
Slightly volatile
Company Equity Multiplier1.712.54462.3253
Very volatile
Long Term Debt To Capitalization0.430.40870.314
Slightly volatile
Total Debt To Capitalization0.240.44680.342
Pretty Stable
Return On Capital Employed0.01790.01880.1175
Pretty Stable
Debt Equity Ratio0.850.80760.5755
Slightly volatile
Ebit Per Revenue0.05460.05740.2546
Slightly volatile
Quick Ratio1.020.69351.3298
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.270.66141.7395
Pretty Stable
Net Income Per E B T2.12.00281.1251
Slightly volatile
Cash Ratio0.05670.05970.1153
Slightly volatile
Cash Conversion Cycle107113161
Slightly volatile
Operating Cash Flow Sales Ratio0.20.14870.2816
Very volatile
Days Of Inventory Outstanding119125209
Slightly volatile
Days Of Sales Outstanding79.8169.741661.9342
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.580.55090.8002
Very volatile
Cash Flow Coverage Ratios0.110.1210.4246
Very volatile
Price To Book Ratio1.731.82512.8203
Pretty Stable
Fixed Asset Turnover2.72.67543.9098
Very volatile
Capital Expenditure Coverage Ratio2.122.22687.799
Slightly volatile
Price Cash Flow Ratio22.1218.673813.5138
Slightly volatile
Enterprise Value Multiple15.6324.552713.1149
Slightly volatile
Debt Ratio0.160.31740.2247
Slightly volatile
Cash Flow To Debt Ratio0.110.1210.4246
Very volatile
Price Sales Ratio4.612.77733.6061
Slightly volatile
Return On Assets0.00890.00940.0775
Pretty Stable
Asset Turnover0.250.25830.3639
Slightly volatile
Net Profit Margin0.03440.03620.2119
Pretty Stable
Gross Profit Margin0.620.49250.7323
Slightly volatile
Price Fair Value1.731.82512.8203
Pretty Stable
Return On Equity0.02260.02380.1765
Pretty Stable

Pfizer Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap126.1 B120.1 B123.8 B
Slightly volatile
Enterprise Value87.3 B83.2 B85.9 B
Slightly volatile

Pfizer Fundamental Market Drivers

Forward Price Earnings8.3682
Cash And Short Term Investments12.7 B

Pfizer Upcoming Events

7th of May 2024
Upcoming Quarterly Report
View
6th of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
4th of February 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

About Pfizer Financial Statements

Pfizer stakeholders use historical fundamental indicators, such as Pfizer's revenue or net income, to determine how well the company is positioned to perform in the future. Although Pfizer investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pfizer's assets and liabilities are reflected in the revenues and expenses on Pfizer's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pfizer Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.7 B3.9 B
Total Revenue58.5 B39.5 B
Cost Of Revenue29.7 B31.2 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.19  0.33 
Research And Ddevelopement To Revenue 0.18  0.13 
Capex To Revenue 0.07  0.06 
Revenue Per Share 10.37  10.88 
Ebit Per Revenue 0.06  0.05 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FFord Motor
GOOGAlphabet Inc Class C
CRMSalesforce
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
How To Invest In Pfizer
Details
Is Pfizer Stock a good investment?
Details
What is Pfizer's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Pfizer Correlation against competitors.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.98)
Dividend Share
1.67
Earnings Share
0.75
Revenue Per Share
10.493
Quarterly Revenue Growth
0.312
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY